SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer

NCT04181645 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Stage IV

Interventions

DRUG: Biological: SHR-1210 Drug: Gemcitabine Drug:Paclitaxel-albumin

Sponsor

RenJi Hospital

Collaborators

[object Object]